LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged 35 u.s.c. § 285 · clear

Federal Circuit

Litigants Face a High Hurdle When Seeking Fees for Unadjudicated Claims

MUNCHKIN, INC. V. LUV N’ CARE LTD Before Dyk, Taranto, and Chen. Appeal from the Central District of California. Summary: when a litigant seeks fees for an exceptional case based on issues that were not fully adjudicated at the district court, the…

June 9, 2020·Federal Circuit·2 min read
PTAB

The Federal Circuit May Not Award Attorney Fees for Work Performed During an IPR

Written by : Adam Powell & T iffany Young AMNEAL PHARMACEUTICALS LLC v. ALMIRALL, LLC Before Dyk, Lourie, and Reyna. Appeal from the Patent Trial and Appeal Board. Summary: While the Federal Circuit may be able to award fees under Section 285 for work…

June 8, 2020·PTAB·1 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.